Skip to main content

The Rarest Stone of All!

  • Chapter
  • First Online:
Urolithiasis
  • 1114 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marcet A. An essay on the chemical history and medical treatment of calculous disorders. London: Longman, Hurst, Rees, Orme, and Brown; 1817.

    Google Scholar 

  2. Prien EL, Frondel C. Studies in urolithiasis: I. The composition of urinary calculi. J Urol. 1947;57:949–91.

    PubMed  CAS  Google Scholar 

  3. Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol. 2005;173(3): 848–57.

    Article  PubMed  Google Scholar 

  4. White DJ, Nancollas GH. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization. Calcif Tissue Int. 1987;40(2):79–84.

    Article  PubMed  CAS  Google Scholar 

  5. Watson RA, Ettinger B, Deshon Jr GE, Agee RE, Oldroyd NO. Triamterene stone: advantage of crystallographic analysis. Urology. 1981;18(3):238–40.

    Article  PubMed  CAS  Google Scholar 

  6. Farrer JH, Rajfer J. Silicate urolithiasis. J Urol. 1984;132(4):739–40.

    PubMed  CAS  Google Scholar 

  7. Lee MH, Lee YH, Hsu TH, Chen MT, Chang LS. Silica stone- development due to long time oral trisilicate intake. Scand J Urol Nephrol. 1993;27(2):267–9.

    Article  PubMed  CAS  Google Scholar 

  8. Albala DM, Prien Jr EL, Galal HA. Urolithiasis as a hazard of sulfonamide therapy. J Endourol. 1994;8(6): 401–3.

    Article  PubMed  CAS  Google Scholar 

  9. Scudi JV, Silber RH. Urinary excretion products of sulfaquinoxaline. J Biol Chem. 1944;156:343–8.

    CAS  Google Scholar 

  10. Scudi JV, Jelinek VC. A distribution method for the differentiation of urinary excretion products of the sulfonamide drugs and the role of these products in urolithiasis. J Pharmacol Exp Ther. 1944;81(3):218–23.

    CAS  Google Scholar 

  11. Schwartz BF, Schenkman N, Armenakas NA, Stoller ML. Imaging characteristics of indinavir calculi. J Urol. 1999;161(4):1085–7.

    Article  PubMed  CAS  Google Scholar 

  12. Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF. Protease inhibitor-induced urolithiasis. Urology. 1997;50(4):508–11.

    Article  PubMed  CAS  Google Scholar 

  13. Matlaga BR, Shah OD, Assimos DG. Drug-induced urinary calculi. Rev Urol. 2003;5(4):227–31.

    PubMed  Google Scholar 

  14. Mulvaney WP, Beck CW, Brown RR. Urinary phenazopyridine stones. JAMA. 1972;221(13):1511–2.

    Article  PubMed  CAS  Google Scholar 

  15. Simmonds HA. 2,8-Dihydroxyadenine lithiasis. Clin Chim Acta. 1986;160(2):103–8.

    Article  PubMed  CAS  Google Scholar 

  16. Klineberg JR, Goldfinger SE, Seegmiller JE. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout. Ann Intern Med. 1965;62:639–47.

    Article  Google Scholar 

  17. Strauven P, Hesse A, Thon A, Behrendt H. Xanthinuria with nephrolithiasis in infancy. Akt Urol. 1989;20: 218–22.

    Article  Google Scholar 

  18. Diven SC. Xanthinuria. http://www.author.emedicine.com/PED/topic2452.htm

  19. Volpe P, Peyrottes A, Lammle M, Saquet D, Choquenet C. Xanthine urinary calculus in a patient with Lesch-Nyhan syndrome. Apropos of a case. Prog Urol. 1997;7:74–7.

    PubMed  CAS  Google Scholar 

  20. Potter JL, Silvidi AA. Xanthine lithiasis, nephrocalcinosis, and renal failure in a leukemia patient treated with allopurinol. Clin Chem. 1987;33:2314–6.

    PubMed  CAS  Google Scholar 

  21. Simmonds HA. 2,8-dihydroxyadenine lithiasis. Clin Chem Acta. 1986;160:103–8.

    Article  CAS  Google Scholar 

  22. Witten FR, Morgan JW, Foster JG, Glenn JF. 2,8-dihydroxyadenine urolithiasis: review of the literature and report of a case in the United States. J Urol. 1983;130:938–42.

    PubMed  CAS  Google Scholar 

  23. Kelley WN, Levy RI, Rosenbloom FM, Henderson JF, Seegmiller JE. Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest. 1968;47(10):2281–9.

    Article  PubMed  CAS  Google Scholar 

  24. Lamontagne Jr AE. 2,8-dihydroxyadenine urolithiasis: report of a case in a woman in the United States. J Urol. 1989;142(2 pt 1):369–70.

    PubMed  Google Scholar 

  25. Usenius JP, Ruopuro ML, Usenius R. Adenine phosphoribosyltransferase deficiency: 2,8-dihydroxyadenine urolithiasis in a 48-year-old woman. Br J Urol. 1988;62(6):521–4.

    Article  PubMed  CAS  Google Scholar 

  26. Greenwood MC, Dillon MJ, Simmonds HA, Barratt TM, Pincott JR, Metreweli C. Renal failure due to 2,8-dihydroxyadenine urolithiasis. Eur J Pediatr. 1982;138(4):346–9.

    Article  PubMed  CAS  Google Scholar 

  27. Yagisawa T, Yamazaki Y, Toma H, Kamatani N. Radiopaque 2,8-dihyroxyadenine lithiasis. Int Urol Nephrol. 1999;31:141–33.

    Article  PubMed  CAS  Google Scholar 

  28. Glicklich D, Gruber HE, Matas AJ, Tellis VA, Karwa G, Finley K, Salem C, Soberman R, Seegmiller JE. 2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant. Q J Med. 1988;68:785–93.

    PubMed  CAS  Google Scholar 

  29. Futcher TB. Dr. Osler’s renal stones. Arch Int Med. 1949;84(1):40.

    Article  Google Scholar 

  30. Bliss M. William Osler: a life in medicine. Oxford: Oxford University Press; 1999.

    Google Scholar 

  31. Osler W. The principles and practice of medicine. New York, NY: Appleton & Co; 1892. p. 766.

    Google Scholar 

  32. Moran ME, Das S, Rosenberg SA. Sir William Osler's perceptions of urolithiasis and the case of the indigo calculus. J Endourol. 2005;19(10):1157–60.

    Article  PubMed  Google Scholar 

  33. Nation EF. William Osler on penis captivus and other urologic topics. Urology. 1973;11:468–70.

    Article  Google Scholar 

  34. Tigertt WD. An annotated life of Egerton Yorrick Davis, MD, an intimate of Sir William Osler. J Hist Med Allied Sci. 1983;38:259–97.

    Article  PubMed  CAS  Google Scholar 

  35. Cushing H. The life of Sir William Osler, vol. 2. Oxford: Oxford, Clareden Press; 1925.

    Google Scholar 

  36. Eisendrath DN, Rolnick HC. Text-book of urology for students and practitioners. Philadelphia, PA: J. B. Lippincott; 1928.

    Google Scholar 

  37. Winsbury-White HP. Stone in the urinary tract. London: Churchill; 1929.

    Google Scholar 

  38. Pfister E. Uber blaue Indigokristalle in agyptischen Blasensteinen. Zeits Urol. 1916:329–41.

    Google Scholar 

  39. Koppeschaar WP. The estimation of indigo blue and indigo red in natural and synthetic indigos. Chem News. 1900;81–82:37.

    Google Scholar 

  40. Blue Urine. Lancet. 1901:1535.

    Google Scholar 

  41. Carter TA. Notes of two cases in which the urine yielded indigo. Med Chir Soc Edinburgh. 1858;July:85–6.

    Google Scholar 

  42. Carter TA. On indican in the blood and urine. Edin Med J. 1859;June:119–29.

    Google Scholar 

  43. Montgomery GN. A case of indicanuria. Lancet. 1908;6:1621.

    Article  Google Scholar 

  44. Ord WM. A calculus largely composed of indigo. Br Med J. 1878;2(917):132–4.

    Article  PubMed  CAS  Google Scholar 

  45. Hawk PB. Practical physiological chemistry. Philadelphia, PA: P. Blakiston’s Sons & Co; 1907. p. 343.

    Google Scholar 

  46. Forbes WS. Indigo calculus from the kidney. Med News. 1894;65:187–8.

    Google Scholar 

  47. Golden RL. A history of William Osler’s the principles and practice of medicine. Montreal: Osler Library, McGill University; 2004.

    Google Scholar 

  48. Fairbanks VF. Blue gods, blue oil, and blue people. Mayo Clin Proc. 1994;69:889–92.

    Article  PubMed  CAS  Google Scholar 

  49. The Nobel prize for chemistry. 1905: Adolf von Baeyer. http:/www.nobel.se/chemistry/laureates/1905/baeyer-bio.html

  50. Ellis JJ. Founding brothers the revolutionary generation. New York, NY: Vintage Books; 2000. p. 18.

    Google Scholar 

  51. Golden RL. William Osler, urolithiasis, and god’s own medicine. Urology. 2009;74(3):517–21.

    Article  PubMed  Google Scholar 

  52. Barondess JA. A case of empyema: notes on the last illness of Sir William Osler. Trans Am Clin Climatol Assoc. 1975;86:59–72.

    PubMed  CAS  Google Scholar 

  53. Arnold WN. King george III’s urine and indigo blue. Lancet. 1996;347(9018):1811–3.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Moran, M.E. (2014). The Rarest Stone of All!. In: Urolithiasis. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8196-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8196-6_26

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8195-9

  • Online ISBN: 978-1-4614-8196-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics